Showing results (1-10 of 13) with videos related to
Sort By:
Pageof 2
Biotechniques|June 20, 2003
Strategies and methods in the identification of antagonists of protein-protein interactionsThomas R GadekBiochemical Pharmacology|December 11, 2002
Small molecule antagonists of proteinsThomas R Gadek, John B NicholasDrug Discovery Today|June 25, 2003
Discovery of small molecule leads in a biotechnology datastreamThomas R Gadek, Robert S McDowellClinical Ophthalmology (Auckland, N.Z.)|June 30, 2016
Development of lifitegrast: a novel T-cell inhibitor for the treatment of dry eye diseaseCharles P Semba, Thomas R GadekBioorganic & Medicinal Chemistry Letters|December 31, 2003
Discovery of novel PTP1b inhibitorsDenise A Ockey, Thomas R GadekJournal of Ocular Pharmacology and Therapeutics : the Official Journal of the Association for Ocular Pharmacology and Therapeutics|December 11, 2012
Corneal inflammation is inhibited by the LFA-1 antagonist, lifitegrast (SAR 1118)Yan Sun, Rui Zhang, Thomas R Gadek, et al.Bioorganic & Medicinal Chemistry Letters|April 15, 2004
N-Benzoyl amino acids as ICAM/LFA-1 inhibitors. Part 2: structure-activity relationship of the benzoyl moietyDaniel J Burdick, James C Marsters, Ignacio Aliagas-Martin, et al.Bioorganic & Medicinal Chemistry|December 31, 2003
Structure-activity relationships by mass spectrometry: identification of novel MMP-3 inhibitorsDenise A Ockey, Jenna L Dotson, Martin E Struble, et al.Bioorganic & Medicinal Chemistry Letters|March 20, 2003
N-Benzoyl amino acids as LFA-1/ICAM inhibitors 1: amino acid structure-activity relationshipDaniel J Burdick, Ken Paris, Kenneth Weese, et al.Journal of Ocular Pharmacology and Therapeutics : the Official Journal of the Association for Ocular Pharmacology and Therapeutics|March 26, 2010
Safety and pharmacokinetics of a novel lymphocyte function-associated antigen-1 antagonist ophthalmic solution (SAR 1118) in healthy adultsCharles P Semba, Dennis Swearingen, Valerie L Smith, et al.Pageof 2